Real-time Estimate
Tradegate
06:49:53 2024-06-27 am EDT
|
5-day change
|
1st Jan Change
|
9.372
EUR
|
+5.92%
|
|
+6.73%
|
-17.36%
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Capitalization
1 |
3,105,395
|
3,161,421
|
3,519,738
|
3,381,409
|
2,946,773
|
2,840,090
|
-
|
-
|
Enterprise Value (EV)
1 |
2,777,545
|
2,829,733
|
3,203,752
|
3,004,569
|
2,611,086
|
3,354,684
|
3,229,435
|
2,734,746
|
P/E ratio
|
16
x
|
26.2
x
|
28.5
x
|
34.7
x
|
173
x
|
38.8
x
|
19.1
x
|
1,989
x
|
Yield
|
2.39%
|
2.47%
|
2.62%
|
3.19%
|
4.26%
|
4.73%
|
5.02%
|
0.06%
|
Capitalization / Revenue
|
2.39
x
|
2.53
x
|
2.72
x
|
2.23
x
|
1.84
x
|
1.7
x
|
1.61
x
|
1.52
x
|
EV / Revenue
|
2.14
x
|
2.26
x
|
2.47
x
|
1.98
x
|
1.63
x
|
2
x
|
1.83
x
|
1.47
x
|
EV / EBITDA
|
8.95
x
|
13.6
x
|
13.6
x
|
12.6
x
|
14.2
x
|
11.2
x
|
8.33
x
|
7.23
x
|
EV / FCF
|
-16.6
x
|
10.3
x
|
14.1
x
|
10.3
x
|
-3.88
x
|
12.1
x
|
12
x
|
11
x
|
FCF Yield
|
-6.04%
|
9.73%
|
7.08%
|
9.7%
|
-25.8%
|
8.26%
|
8.3%
|
9.09%
|
Price to Book
|
2.41
x
|
2.28
x
|
2.39
x
|
2.24
x
|
1.85
x
|
1.89
x
|
1.86
x
|
1.98
x
|
Nbr of stocks (in thousands)
|
1,858,405
|
1,857,474
|
1,841,831
|
1,795,756
|
1,792,986
|
1,792,986
|
-
|
-
|
Reference price
2 |
1,671
|
1,702
|
1,911
|
1,883
|
1,644
|
1,584
|
1,584
|
1,584
|
Announcement Date
|
5/14/20
|
4/27/21
|
4/27/22
|
4/27/23
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net sales
1 |
1,300,843
|
1,249,528
|
1,296,163
|
1,518,619
|
1,603,672
|
1,674,100
|
1,761,153
|
1,865,158
|
EBITDA
1 |
310,387
|
208,703
|
235,370
|
238,767
|
183,358
|
299,736
|
387,830
|
378,356
|
EBIT
1 |
243,991
|
136,051
|
155,686
|
133,029
|
25,518
|
126,667
|
214,518
|
210,025
|
Operating Margin
|
18.76%
|
10.89%
|
12.01%
|
8.76%
|
1.59%
|
7.57%
|
12.18%
|
11.26%
|
Earnings before Tax (EBT)
1 |
245,350
|
145,324
|
156,886
|
132,361
|
24,969
|
99,307
|
195,209
|
269,271
|
Net income
1 |
195,411
|
120,589
|
124,086
|
98,714
|
17,045
|
73,228
|
148,189
|
142,797
|
Net margin
|
15.02%
|
9.65%
|
9.57%
|
6.5%
|
1.06%
|
4.37%
|
8.41%
|
7.66%
|
EPS
2 |
104.2
|
64.93
|
67.08
|
54.24
|
9.510
|
0.2462
|
0.7266
|
0.7965
|
Free Cash Flow
1 |
-167,795
|
275,459
|
226,705
|
291,326
|
-673,327
|
276,987
|
268,019
|
248,559
|
FCF margin
|
-12.9%
|
22.05%
|
17.49%
|
19.18%
|
-41.99%
|
16.55%
|
15.22%
|
13.33%
|
FCF Conversion (EBITDA)
|
-
|
131.99%
|
96.32%
|
122.01%
|
-
|
92.41%
|
69.11%
|
65.69%
|
FCF Conversion (Net income)
|
-
|
228.43%
|
182.7%
|
295.12%
|
-
|
378.25%
|
180.86%
|
174.06%
|
Dividend per Share
2 |
40.00
|
42.00
|
50.00
|
60.00
|
70.00
|
74.87
|
79.56
|
0.9500
|
Announcement Date
|
5/14/20
|
4/27/21
|
4/27/22
|
4/27/23
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: March |
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
2025 S2
|
2026 Q1
|
2026 S1
|
2026 S2
|
2027 S1
|
---|
Net sales
1 |
-
|
615,480
|
-
|
651,666
|
340,627
|
303,870
|
-
|
381,791
|
380,394
|
762,185
|
402,180
|
354,254
|
374,990
|
392,148
|
767,138
|
421,932
|
414,602
|
-
|
409,469
|
426,700
|
814,224
|
443,793
|
395,939
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
70,087
|
42
|
-
|
89,100
|
81,600
|
-
|
113,400
|
9,300
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
86,872
|
-
|
90,169
|
79,202
|
-13,685
|
-
|
33,147
|
86,744
|
119,891
|
61,388
|
-48,250
|
45,794
|
5,222
|
51,016
|
23,103
|
-48,601
|
-
|
39,895
|
47,538
|
101,294
|
61,917
|
-13,858
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
14.11%
|
-
|
13.84%
|
23.25%
|
-4.5%
|
-
|
8.68%
|
22.8%
|
15.73%
|
15.26%
|
-13.62%
|
12.21%
|
1.33%
|
6.65%
|
5.48%
|
-11.72%
|
-
|
9.74%
|
11.14%
|
12.44%
|
13.95%
|
-3.5%
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
89,091
|
-
|
89,085
|
78,317
|
-10,516
|
-
|
31,679
|
88,801
|
120,480
|
59,758
|
-47,877
|
46,850
|
5,328
|
52,178
|
21,452
|
-48,661
|
-
|
33,814
|
39,822
|
64,944
|
53,621
|
-15,772
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
72,838
|
-
|
71,609
|
60,886
|
-8,409
|
-
|
24,812
|
71,622
|
96,434
|
48,405
|
-46,125
|
33,129
|
-1,459
|
31,670
|
18,653
|
-33,278
|
-
|
26,199
|
31,033
|
49,478
|
41,787
|
-12,009
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
11.83%
|
-
|
10.99%
|
17.87%
|
-2.77%
|
-
|
6.5%
|
18.83%
|
12.65%
|
12.04%
|
-13.02%
|
8.83%
|
-0.37%
|
4.13%
|
4.42%
|
-8.03%
|
-
|
6.4%
|
7.27%
|
6.08%
|
9.42%
|
-3.03%
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-
|
39.21
|
-
|
38.65
|
32.86
|
-4.430
|
-
|
13.59
|
39.28
|
52.87
|
26.56
|
-25.19
|
18.46
|
-0.8000
|
17.66
|
10.40
|
-18.55
|
-
|
9.885
|
14.12
|
33.40
|
20.20
|
-19.31
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
20.00
|
21.00
|
21.00
|
25.00
|
-
|
-
|
25.00
|
-
|
-
|
30.00
|
-
|
-
|
-
|
35.00
|
35.00
|
-
|
35.00
|
35.00
|
-
|
-
|
37.00
|
-
|
-
|
37.00
|
-
|
39.00
|
39.00
|
41.00
|
Announcement Date
|
5/14/20
|
10/30/20
|
4/27/21
|
10/29/21
|
2/2/22
|
4/27/22
|
4/27/22
|
8/1/22
|
10/31/22
|
10/31/22
|
2/6/23
|
4/27/23
|
8/1/23
|
11/1/23
|
11/1/23
|
2/5/24
|
4/25/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
514,594
|
389,344
|
-
|
Net Cash position
1 |
327,850
|
331,688
|
315,986
|
376,840
|
335,687
|
-
|
-
|
105,344
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
1.717
x
|
1.004
x
|
-
|
Free Cash Flow
1 |
-167,795
|
275,459
|
226,705
|
291,326
|
-673,327
|
276,987
|
268,019
|
248,559
|
ROE (net income / shareholders' equity)
|
15.3%
|
9%
|
8.7%
|
6.7%
|
1.1%
|
5.61%
|
10.1%
|
12%
|
ROA (Net income/ Total Assets)
|
11.6%
|
6.33%
|
6.81%
|
5.53%
|
3.28%
|
3.65%
|
6.24%
|
6.24%
|
Assets
1 |
1,678,858
|
1,905,121
|
1,821,523
|
1,785,770
|
519,665
|
2,005,015
|
2,374,250
|
2,286,946
|
Book Value Per Share
2 |
694.0
|
748.0
|
799.0
|
839.0
|
890.0
|
835.0
|
817.0
|
802.0
|
Cash Flow per Share
2 |
140.0
|
104.0
|
110.0
|
112.0
|
97.50
|
1.690
|
1.920
|
1.910
|
Capex
1 |
41,267
|
31,384
|
30,739
|
36,441
|
38,056
|
60,500
|
54,700
|
50,500
|
Capex / Sales
|
3.17%
|
2.51%
|
2.37%
|
2.4%
|
2.37%
|
3.61%
|
3.11%
|
2.71%
|
Announcement Date
|
5/14/20
|
4/27/21
|
4/27/22
|
4/27/23
|
4/25/24
|
-
|
-
|
-
|
Last Close Price
1,584
JPY Average target price
1,855
JPY Spread / Average Target +17.13% Consensus |
1st Jan change
|
Capi.
|
---|
| +54.61% | 811B | | +43.48% | 640B | | -6.33% | 353B | | +20.62% | 333B | | +10.44% | 302B | | +17.62% | 246B | | +2.37% | 225B | | +12.44% | 218B | | +8.61% | 168B |
Other Pharmaceuticals
|